Personalized infliximab rescue therapy to maximize colectomy-free survival in patients with acute severe ulcerative colitis
Key Points
The aim was to create a predictive framework for assessing colectomy risk in patients with acute severe ulcerative colitis (ASUC).
Developed a dose-exposure-response model to understand colectomy risk.
Integrated the model into an interactive tool for personalized therapy decisions.
Focused on utilizing infliximab as a rescue therapy for ASUC.
The predictive framework can identify patients at high risk for colectomy.
The interactive tool enables healthcare providers to tailor infliximab dosing.
Individualized therapy aims to improve colectomy-free survival rates.
Abstract
We developed a model-based dose-exposure-response framework to predict colectomy risk in ASUC. We integrated the algorithm into an interactive tool to enable individualized infliximab rescue therapy.